Form 4: LifeMD's Chief Innovation Officer, Stefan Galluppi, Acquires 3,000 Shares
SEC Form 4 Filing
Stefan Galluppi, Chief Innovation Officer of LifeMD, Inc., purchased 3,000 shares of common stock at an average price of $4.93 on September 11, 2024.
Summary
- On September 11, 2024, Stefan Galluppi, the Chief Innovation Officer of LifeMD, Inc., acquired 3,000 shares of common stock.
- The purchase price was $4.93 per share.
- The total number of shares beneficially owned by Galluppi following the transaction is 45,449.
- The shares were purchased in multiple transactions at prices ranging from $4.92 to $4.9299 per share.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports an insider transaction. It doesn't inherently indicate positive or negative sentiment about the company's future.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor management's confidence in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 09/11/2024 | Date of transaction: Stefan Galluppi purchased 3,000 shares of LifeMD common stock. |
| 09/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.